David Toung
Stock Analyst at Argus Research
(4.20)
# 433
Out of 5,139 analysts
131
Total ratings
65.35%
Success rate
9.8%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCA HCA Healthcare | Maintains: Buy | $530 → $560 | $528.66 | +5.93% | 3 | Feb 6, 2026 | |
| HOLX Hologic | Downgrades: Hold | n/a | $75.14 | - | 3 | Jan 12, 2026 | |
| TECH Bio-Techne | Maintains: Buy | $65 → $68 | $58.25 | +16.74% | 4 | Nov 20, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $580 → $610 | $515.12 | +18.42% | 8 | Oct 29, 2025 | |
| MDT Medtronic | Maintains: Buy | $105 → $115 | $97.58 | +17.85% | 7 | Aug 26, 2025 | |
| HUM Humana | Reiterates: Hold | $282 | $190.50 | +48.03% | 9 | Aug 14, 2025 | |
| ELV Elevance Health | Downgrades: Hold | n/a | $348.18 | - | 4 | Jul 21, 2025 | |
| GFS GlobalFoundries | Initiates: Buy | $52 | $45.44 | +14.44% | 1 | Jul 1, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $289.93 | - | 8 | Apr 21, 2025 | |
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $12.05 | - | 2 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $224.35 | - | 6 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $125 | $222.76 | -43.89% | 9 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $164.24 | - | 5 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $340 | $375.50 | -9.45% | 10 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $570 → $670 | $937.14 | -28.51% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $99.25 | +51.13% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $1,023.22 | -17.91% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $83.01 | +32.51% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $282.48 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $26.86 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $372.66 | -16.81% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $499.53 | -35.94% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $112.19 | +20.33% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $151.12 | -50.37% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $60.30 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $121.86 | -9.73% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.88 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $208.62 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $163.92 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $246.91 | -37.22% | 4 | Mar 27, 2020 |
HCA Healthcare
Feb 6, 2026
Maintains: Buy
Price Target: $530 → $560
Current: $528.66
Upside: +5.93%
Hologic
Jan 12, 2026
Downgrades: Hold
Price Target: n/a
Current: $75.14
Upside: -
Bio-Techne
Nov 20, 2025
Maintains: Buy
Price Target: $65 → $68
Current: $58.25
Upside: +16.74%
Thermo Fisher Scientific
Oct 29, 2025
Maintains: Buy
Price Target: $580 → $610
Current: $515.12
Upside: +18.42%
Medtronic
Aug 26, 2025
Maintains: Buy
Price Target: $105 → $115
Current: $97.58
Upside: +17.85%
Humana
Aug 14, 2025
Reiterates: Hold
Price Target: $282
Current: $190.50
Upside: +48.03%
Elevance Health
Jul 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $348.18
Upside: -
GlobalFoundries
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $45.44
Upside: +14.44%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $289.93
Upside: -
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $12.05
Upside: -
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $224.35
Upside: -
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $222.76
Upside: -43.89%
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $164.24
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $375.50
Upside: -9.45%
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $937.14
Upside: -28.51%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $99.25
Upside: +51.13%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $1,023.22
Upside: -17.91%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $83.01
Upside: +32.51%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $282.48
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $26.86
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $372.66
Upside: -16.81%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $499.53
Upside: -35.94%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $112.19
Upside: +20.33%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $151.12
Upside: -50.37%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $60.30
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $121.86
Upside: -9.73%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $4.88
Upside: -
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $208.62
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $163.92
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $246.91
Upside: -37.22%